Effects of modified ligation of intersphincteric fistula tract on intestinal barrier function in patients with transsphincteric anal fistula
World Journal of Gastrointestinal Surgery · 2026-11-27 · 18 (11)
DOI: 10.4240/wjgs.120547 ↗Abstract
BACKGROUND The treatment for transsphincteric anal fistula (TAF) remains challenging. Effective therapies that achieve high efficacy and low recurrence while preserving anal sphincter function are still lacking. AIM To analyze the effects of modified ligation of intersphincteric fistula tract (LIFT) on infection-related parameters and intestinal barrier function in patients with TAF. METHODS A total of 101 patients with TAF admitted to the First Affiliated Hospital of Jinan University between January 2022 and June 2024 were retrospectively enrolled. Patients were grouped according to the treatment received: The control group (n = 49) underwent conventional anal fistulectomy, whereas the research group (n = 52) underwent modified LIFT. Clinical efficacy, surgical outcomes (e.g. , operation time, hospitalization, wound healing time, and postoperative scar area), anal sphincter function assessed using Wexner score, pain intensity assessed using Visual Analogue Scale, infection-related parameters, including white blood cell count, C-reactive protein, and procalcitonin, intestinal barrier function, including diamine oxidase and D-lactic acid, complications, including anal canal deformity, anal edema, infection, constipation, and urinary retention), and the one-year recurrence rate were compared between groups. RESULTS Compared with the control group, the research group exhibited a significantly higher total effective rate, shorter operation time, hospitalization, and wound healing time, a smaller postoperative scar area, lower postoperative Wexner and Visual Analogue Scale scores, lower levels of infection-related parameters, and reduced overall complication and one-year recurrence rates. Postoperative intestinal barrier function indicators were comparable between groups. CONCLUSION These findings suggest that modified LIFT demonstrates reliable efficacy and safety in patients with TAF.
EUVIMED